Literature DB >> 12591017

Contribution to characterization of oxidative stress in HIV/AIDS patients.

Lizette Gil1, Gregorio Martínez, Ivón González, Alicia Tarinas, Alejandro Alvarez, A Giuliani, Randelis Molina, Rolando Tápanes, Jorge Pérez, Olga Sonia León.   

Abstract

Infection by human immunodeficiency virus (HIV) causes persistent chronic inflammation. Viral Tat protein plays a role in the intracellular increase of reactive oxygen species (ROS) thus increasing apoptotic index, mostly the one mediated by FAS/CD95, and depleting CD4+ T lymphocytes. The aim of this study was to investigate whether there is a relationship between an extensive array of redox status indices (glutathione (GSH), malondialdehyde (MDA), peroxidation potential, total antioxidant status, glutathione peroxidase (GPx), superoxide dismutase (SOD), total hydroperoxide (TH), DNA fragmentation) and relative CD4, CD95, CD38/CD8 T lymphocyte counts in HIV/AIDS patients compared to healthy subjects. Blood samples from 85 HIV/AIDS patients and 40 healthy subjects were tested by spectrophotometric techniques in order to measure oxidative stress indices, and by flow cytometry to quantify T cell subsets. Patients were divided in two groups according to CDC 1993 guidelines. CD95 and CD38 increase paralleled the severity of HIV infection. Both a reduction of GSH levels and an increase in MDA and TH levels were detected in the plasma of HIV+ patients. These patients also showed an increase of DNA fragmentation in lymphocytes as well as a significant (P<0.05) reduction of GPx and an increase in SOD activity in erythrocytes. Relatively to the control group, HIV-infected patients had significantly differences in global indices of total antioxidant status. These results corroborate that substantial oxidative stress occurs during HIV infection. To our knowledge this study is the first relating oxidative stress indices with both CD38/CD8 and CD95 lymphocytes subsets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591017     DOI: 10.1016/s1043-6618(02)00320-1

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  51 in total

1.  Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.

Authors:  M K Baum; S Sales; D T Jayaweera; S Lai; G Bradwin; C Rafie; J B Page; A Campa
Journal:  HIV Med       Date:  2011-02       Impact factor: 3.180

2.  The role of mutation accumulation in HIV progression.

Authors:  Alison P Galvani
Journal:  Proc Biol Sci       Date:  2005-09-07       Impact factor: 5.349

3.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

4.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

5.  PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.

Authors:  Wen Huang; Ibolya E András; Geun Bae Rha; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2011-08-12       Impact factor: 5.191

6.  Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.

Authors:  S A Pereira; J R Batuca; U Caixas; T Branco; J Delgado-Alves; I Germano; F Lampreia; E C Monteiro
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

7.  Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma.

Authors:  Susan R Mallery; Ping Pei; David J Landwehr; Christopher M Clark; Jennifer E Bradburn; Gregory M Ness; Fredika M Robertson
Journal:  Carcinogenesis       Date:  2003-12-04       Impact factor: 4.944

8.  BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells.

Authors:  Alessandra Rosati; Kamel Khalili; Satish L Deshmane; Sujatha Radhakrishnan; Maria Pascale; M Caterina Turco; Liberato Marzullo
Journal:  J Cell Physiol       Date:  2009-02       Impact factor: 6.384

9.  Reconciling conflicting clinical studies of antioxidant supplementation as HIV therapy: a mathematical approach.

Authors:  Rolina D van Gaalen; Lindi M Wahl
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

10.  Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy.

Authors:  Antonella Mandas; Eugenio Luigi Iorio; Maria Gabriella Congiu; Cinzia Balestrieri; Antonello Mereu; Daniela Cau; Sandra Dessì; Nicoletta Curreli
Journal:  J Biomed Biotechnol       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.